S

Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ

Watchlist Manager
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
Watchlist
Price: 15 175 IDR
Market Cap: Rp185.7T

EV/FCFF

-394.1
Current
337%
More Expensive
vs 3-y average of -90.2

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
-394.1
=
Enterprise Value
Rp188.7T
/
Free Cash Flow to Firm
Rp-478.2B

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
-394.1
=
Enterprise Value
Rp188.7T
/
Free Cash Flow to Firm
Rp-478.2B

Valuation Scenarios

Sejahteraraya Anugrahjaya Tbk PT is trading above its industry average

If EV/FCFF returns to its Industry Average (29.8), the stock would be worth Rp-1 148.54 (108% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-108%
Maximum Upside
No Upside Scenarios
Average Downside
105%
Scenario EV/FCFF Value Implied Price Upside/Downside
Current Multiple -394.1 Rp15 175
0%
Industry Average 29.8 Rp-1 148.54
-108%
Country Average 9.6 Rp-368.59
-102%

Forward EV/FCFF
Today’s price vs future free cash flow to firm

Not enough data available to calculate forward EV/FCFF

Peer Comparison

All Multiples
EV/FCFF
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in Indonesia
Percentile
0th
Based on 572 companies
0th percentile
-394.1
Low
0 — 5.7
Typical Range
5.7 — 18
High
18 —
Distribution Statistics
Indonesia
Min 0
30th Percentile 5.7
Median 9.6
70th Percentile 18
Max 1 364 898.3

Sejahteraraya Anugrahjaya Tbk PT
Glance View

Market Cap
185.7T IDR
Industry
Health Care

Sejahteraraya Anugrahjaya Tbk PT, widely recognized as a pivotal player in Indonesia’s healthcare sector, stands out for its commitment to providing high-quality medical services through its premier brand, Mayapada Hospital. The company operates an expanding network of hospitals strategically positioned to serve Indonesia's bustling metropolitan areas, catering to a diverse demographic in need of trusted and reliable healthcare. Each facility under Sejahteraraya Anugrahjaya is equipped with advanced medical technology and accredited healthcare professionals, which not only attract domestic patients but also garner interest from international clientele seeking specialized treatment. This emphasis on quality and accessibility forms the backbone of its business model, while diversifying services ensures both steady revenue flow and resilience against economic fluctuations. By focusing on a broad range of healthcare services—from general consultations and diagnostics to specialized medical treatments and emergency care—Sejahteraraya Anugrahjaya Tbk PT secures various revenue streams. The institution capitalizes on Indonesia's growing demand for healthcare services driven by its burgeoning middle class and increasing health consciousness among the population. Insurance partnerships and direct patient payments constitute primary income channels, further enhanced by healthcare innovations and expansions. Through continuous investments in building state-of-the-art facilities and fostering strategic alliances, the company adeptly navigates the competitive healthcare landscape, ensuring sustainable growth and setting a benchmark for medical excellence in the region.

SRAJ Intrinsic Value
371.32 IDR
Overvaluation 98%
Intrinsic Value
Price Rp15 175
S
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett